Chimerix, Inc. Announces Second Quarter 2013 Financial Results

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DURHAM, N.C., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported financial results for the quarter ended June 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news